BMI View: It is vital that the New Zealand government assesses the sustainability of its healthcare system. The country has traditionally had high state-healthcare expenditure, with patients enjoying easy access to doctors and specialists. Furthermore, the government currently accounts for more than three-quarters of healthcare spending, and the expanding and ageing population will mean that demand for healthcare stays high. Headline Expenditure Forecasts ? Pharmaceuticals: NZD1.38bn (US$1.12bn) in 2012 to NZD1.42bn (US$1.14bn) in 2013; +2.8% in local currency and 1.6% in US dollar terms. ? Healthcare: NZD21.25bn (US$17.218bn) in 2012 to NZD22.04bn (US$17.63bn) in 2013; +3.9% in local currency and …
Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=131635.
Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/new-zealand-pharmaceuticals-and-healthcare-report-q1-2014-market-report.html.
No comments:
Post a Comment